TRNV: A Mitochondrial Protein Regulating Gene Expression and Cellular Respiration

Target Name: TRNV

NCBI ID: G4577

TRNV

Other Name(s): mitochondrially encoded tRNA-Val (GUN) | mitochondrially encoded tRNA valine | MT-TV | MTTV

TRNV: A Mitochondrial Protein Regulating Gene Expression and Cellular Respiration

TRNV, or mitochondrially encoded tRNA-Val (GUN), is a protein that plays a crucial role in the regulation of gene expression in the mitochondria. It is a small non-coding RNA molecule that is synthesized from the amino acid Valine (Val) in the cytosol of the mitochondria.

The mitochondria are organelles that are found inside the cells, they are responsible for generating the energy needed by the cell through a process called cellular respiration. The mitochondria also play a key role in the regulation of gene expression, by controlling the translation of mRNAs into proteins.

TRNV is a protein that is encoded by the mitochondrial gene KIAA1. It is a small non-coding RNA molecule that is synthesized from the amino acid Valine (Val) in the cytosol of the mitochondria. It is a key regulator of gene expression in the mitochondria, and is involved in the regulation of cellular respiration and the production of energy in the cell.

One of the key functions of TRNV is its role in the regulation of the translation of mRNAs into proteins. It does this by binding to specific sequences in the mRNAs that it is involved in, and by helping to ensure that these mRNAs are properly translated into the correct proteins. This is important for the proper functioning of the mitochondria and the cell as a whole.

Another function of TRNV is its role in the regulation of cellular respiration. Mitochondria are the primary organelles responsible for generating the energy needed by the cell through cellular respiration. TRNV is involved in the regulation of the production of ATP, which is the energy currency of the cell, from the process of cellular respiration.

TRNV is also involved in the regulation of the levels of mitochondrial enzymes. These enzymes are responsible for various cellular functions, including the production of energy from the food we eat. By regulating the levels of these enzymes, TRNV helps to ensure that the cell has access to the energy it needs to function properly.

TRNV is also involved in the regulation of the stress response. The stress response is a critical part of the cell's ability to respond to environmental changes and to repair damage to the cell. TRNV is involved in the regulation of the stress response by binding to specific stress-responsive genes and helping to ensure that they are properly activated.

TRNV is also a potential drug target and a biomarker. The over-expression of TRNV has been reported to be associated with various diseases, including cancer, neurodegenerative diseases, and metabolic diseases. Also, TRNV has been shown to be downregulated in various diseases, including neurodegenerative diseases, cancer, and metabolic diseases.

In conclusion, TRNV is a protein that plays a crucial role in the regulation of gene expression in the mitochondria. It is a small non-coding RNA molecule that is synthesized from the amino acid Valine (Val) in the cytosol of the mitochondria, and it is involved in the regulation of the translation of mRNAs into proteins, cellular respiration, the production of ATP, the regulation of the stress response, and it is a potential drug target and biomarker. Further studies are needed to fully understand the role of TRNV in the regulation of gene expression in the mitochondria and its potential as a drug target and biomarker.

Protein Name: Mitochondrially Encoded TRNA Valine

The "TRNV Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRNV comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets